Evidence map›Paper›PMID 40012184›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

The D-Dimer/Albumin Ratio as a Novel Biomarker for Predicting the Efficacy of Oral Tirofiban in Patients with Cerebral Infarction.

Xiaohui Li, Huimin Guo, Caixia Guo, Mingyang Wei, Chen Wang, Jianbin Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaohui LiDepartment of Neurology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Huimin GuoDepartment of Neurology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Caixia GuoDepartment of Neurology, Xinzhou People's Hospital, Xinzhou, China.
Mingyang WeiDepartment of Neurology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Chen WangDepartment of Neurology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Jianbin ZhangDepartment of Neurology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.ORCID 0009-0007-9869-3755

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cerebral InfarctionFibrin Fibrinogen Degradation ProductsPlatelet Aggregation InhibitorsTirofibanAdministration, OralAgedBiomarkersFemaleHumansMaleMiddle AgedBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment DPlatelet Aggregation InhibitorsTirofibanbiomarkercerebral infarctionD-dimer/albumin ratiotirofiban

Identifiers

PMID40012184
PMCPMC11866371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.